The future trajectory of adverse outcome pathways: a commentary

被引:0
|
作者
Fiona Sewell
Nichola Gellatly
Maria Beaumont
Natalie Burden
Richard Currie
Lolke de Haan
Thomas H. Hutchinson
Miriam Jacobs
Catherine Mahony
Ian Malcomber
Jyotigna Mehta
Graham Whale
Ian Kimber
机构
[1] National Centre for the Replacement,School of Geography, Earth and Environmental Sciences
[2] Refinement and Reduction of Animals in Research (NC3Rs),Faculty of Biology, Medicine and Health
[3] GlaxoSmithKline,undefined
[4] Syngenta Ltd.,undefined
[5] Jealott’s Hill International Research Centre,undefined
[6] MedImmune,undefined
[7] University of Plymouth,undefined
[8] Public Health England,undefined
[9] Procter and Gamble Company,undefined
[10] Unilever,undefined
[11] Safety and Environmental Assurance Centre,undefined
[12] Dow AgroSciences,undefined
[13] European Development Centre,undefined
[14] Shell,undefined
[15] Health,undefined
[16] Shell Centre,undefined
[17] University of Manchester,undefined
来源
Archives of Toxicology | 2018年 / 92卷
关键词
Adverse outcome pathways (AOPs); Hazard identification; Safety assessment; Risk assessment;
D O I
暂无
中图分类号
学科分类号
摘要
The advent of adverse outcome pathways (AOPs) has provided a new lexicon for description of mechanistic toxicology, and a renewed enthusiasm for exploring modes of action resulting in adverse health and environmental effects. In addition, AOPs have been used successfully as a framework for the design and development of non-animal approaches to toxicity testing. Although the value of AOPs is widely recognised, there remain challenges and opportunities associated with their use in practise. The purpose of this article is to consider specifically how the future trajectory of AOPs may provide a basis for addressing some of those challenges and opportunities.
引用
收藏
页码:1657 / 1661
页数:4
相关论文
共 50 条
  • [41] Fetal growth trajectory assessed by customised limits and adverse perinatal outcome
    Francis, A.
    Hugh, O.
    Gardosi, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 62 - 62
  • [42] Fetal growth trajectory assessed by customised limits and adverse perinatal outcome
    Francis, A.
    Hugh, O.
    Turner, S.
    Williams, M.
    Gardosi, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 62 - 63
  • [43] A brief commentary on the past, present and future trajectory of the Journal of World Business
    Harvey, Michael G.
    Moeller, Miriam
    JOURNAL OF WORLD BUSINESS, 2016, 51 (01) : 6 - 9
  • [44] In Response: Quantitative adverse outcome pathways for prediction of adverse effects-An academic perspective
    Scholz, Stefan
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2015, 34 (09) : 1935 - 1937
  • [45] Adverse Outcome Pathways for Chronic Copper Toxicity to Fish and Amphibians
    Brix, Kevin, V
    De Boeck, Gudrun
    Baken, Stijn
    Fort, Douglas J.
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2022, 41 (12) : 2911 - 2927
  • [46] Unravelling essential key events in mitochondrial adverse outcome pathways
    van der Stel, W.
    Darici, S.
    van de Water, B.
    Danen, E.
    TOXICOLOGY LETTERS, 2018, 295 : S193 - S194
  • [47] The use of adverse outcome pathways in the safety evaluation of food additives
    Vinken, Mathieu
    Kramer, Nynke
    Allen, Timothy E. H.
    Hoffmans, Yvette
    Thatcher, Natalie
    Levorato, Sara
    Traussnig, Heinz
    Schulte, Stefan
    Boobis, Alan
    Thiel, Anette
    Rietjens, Ivonne M. C. M.
    ARCHIVES OF TOXICOLOGY, 2020, 94 (03) : 959 - 966
  • [48] A Strategy Towards the Generation of Testable Adverse Outcome Pathways for Nanomaterials
    Murugadoss, Sivakumar
    Vrcek, Ivana Vinkovic
    Pem, Barbara
    Jagiello, Karolina
    Judzinska, Beata
    Sosnowska, Anita
    Martens, Marvin
    Willighagen, Egon L.
    Puzyn, Tomasz
    Dusinska, Maria
    Cimpan, Mihaela Roxana
    Fessard, Valerie
    Hoet, Peter H.
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2021, 38 (04) : 580 - 594
  • [49] INT: OECD launches a new series on adverse outcome pathways
    Balcombe, Jonathan
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2016, 33 (04) : 481 - 481